RT @giordanopg: Nueva revisión Cochrane que resalta lo bueno y lo incierto de las pruebas de anticuerpos: https://t.co/UgGzq1PWUe
RT @unibirm_MDS: #COVID19 | Led by Professor Jon Deeks (@deeksj), scientists have analysed worldwide data to examine the accuracy of #antib…
RT @tlassers: Test timing best in testing times? #COVID19 antibody test accuracy assessed in new @CochraneLibrary review https://t.co/qsrJ…
Very important thread explaining @deeksj @cochranecollab MA on diagnostic accuracy for current and past Ab testing for SARS-CoV-2 #COVID19
RT @GSCollins: Two #covid19 reviews one on diagnostic & prognostic prediction models (https://t.co/2bp1HHDDUc) and this new one on diagnost…
RT @CochraneJapan: COVID19の抗体検査の診断精度レビューが出版されました! 感度は非常に低く診断には有用でなさそうでした。一方、症状発症後15日以上経過しての使用は既感染の検出に有用な可能性が高いです。ただ、抗体の上昇期間は不明であり、症状発症後35日を…
RT @giordanopg: Nueva revisión Cochrane que resalta lo bueno y lo incierto de las pruebas de anticuerpos: https://t.co/UgGzq1PWUe
RT @unibirm_MDS: #COVID19 | Led by Professor Jon Deeks (@deeksj), scientists have analysed worldwide data to examine the accuracy of #antib…
RT @CochraneJapan: COVID19の抗体検査の診断精度レビューが出版されました! 感度は非常に低く診断には有用でなさそうでした。一方、症状発症後15日以上経過しての使用は既感染の検出に有用な可能性が高いです。ただ、抗体の上昇期間は不明であり、症状発症後35日を…
Antibody tests for identification of current and past infection with SARS‐CoV‐2 - Deeks, JJ - 2020 | Cochrane Library - https://t.co/6YV1J8vumE
RT @giordanopg: Nueva revisión Cochrane que resalta lo bueno y lo incierto de las pruebas de anticuerpos: https://t.co/UgGzq1PWUe
Phenomenal thread (from someones actual domain of expertise) on the test performance of serology for #COVID19
RT @ccaneloa: . @cochranecollab SR of #COVIDー19 sensitivity of IgG/IgM testing depends on # of days post-onset of symptoms: -30.1% (95% CI…
Revisión sobre las pruebas de anticuerpos
Antibody tests for identification of current and past infection with SARS‐CoV‐2 - Deeks, JJ - 2020 | Cochrane Library https://t.co/XAd5PiBcKb
RT @unibirm_MDS: #COVID19 | Led by Professor Jon Deeks (@deeksj), scientists have analysed worldwide data to examine the accuracy of #antib…
Two #covid19 reviews one on diagnostic & prognostic prediction models (https://t.co/2bp1HHDDUc) and this new one on diagnostic tests (https://t.co/nhb9vAxjev). Similar conclusions: preprint concerns, and design, execution and reporting require consider
RT @CochraneSweden: Väldigt aktuell kunskapsöversikt om testning av antikroppar för pågående eller tidigare SARS-CoV-2 smitta. Spännande fö…
“The sensitivity of antibody tests is too low in the first week but may still have a role complementing other testing in individuals presenting later, when RT‐PCR tests are negative, or are not done” https://t.co/ZuV7D1E4gp sample cohorts too small so can
RT @tlassers: Test timing best in testing times? #COVID19 antibody test accuracy assessed in new @CochraneLibrary review https://t.co/qsrJ…
. @cochranecollab SR of #COVIDー19 sensitivity of IgG/IgM testing depends on # of days post-onset of symptoms: -30.1% (95% CI 21.4 to 40.7) at 1 to 7 days -72.2% (95% CI 63.5 to 79.5) for 8 to 14 days -91.4% (95% CI 87.0 to 94.4) for 15 to 21 days https:/
RT @CochraneSweden: Väldigt aktuell kunskapsöversikt om testning av antikroppar för pågående eller tidigare SARS-CoV-2 smitta. Spännande fö…
RT @unibirm_MDS: #COVID19 | Led by Professor Jon Deeks (@deeksj), scientists have analysed worldwide data to examine the accuracy of #antib…
RT @giordanopg: Nueva revisión Cochrane que resalta lo bueno y lo incierto de las pruebas de anticuerpos: https://t.co/UgGzq1PWUe
RT @giordanopg: Nueva revisión Cochrane que resalta lo bueno y lo incierto de las pruebas de anticuerpos: https://t.co/UgGzq1PWUe
In meinem Freundi-Kreis warten immer mehr mit einem Antikörpertest auf (mit negativem Ergebnis). Ich würd sagen, die knapp 20 Euro waren rausgeschmissenes Geld. Danke für die gute Übersichtsarbeit @Cochrane_DE https://t.co/T7rHZTCBHk fh
RT @dccrene: Can we use antibody tests to show past infections? Timing is everything but most data from patients who were hospitalised so h…
RT @giordanopg: Nueva revisión Cochrane que resalta lo bueno y lo incierto de las pruebas de anticuerpos: https://t.co/UgGzq1PWUe
RT @cochranecollab: JUST PUBLISHED - Antibody tests for identification of current and past infection with SARS‐CoV‐2 https://t.co/QTVoiTtDM…
Antibody tests for identification of current and past infection with SARS‐CoV‐2 - Deeks, JJ - 2020 | Cochrane Library https://t.co/1zR9FRJLEh Living Cochrane Review of Antibody Tests – 1st version now published. Twitter summary to save you reading the 30
RT @unibirm_MDS: #COVID19 | Led by Professor Jon Deeks (@deeksj), scientists have analysed worldwide data to examine the accuracy of #antib…
RT @CochraneLibrary: JUST PUBLISHED - Antibody tests for identification of current and past infection with SARS‐CoV‐2 https://t.co/95qFRShB…
RT @cochranecollab: JUST PUBLISHED - Antibody tests for identification of current and past infection with SARS‐CoV‐2 https://t.co/QTVoiTtDM…
RT @unibirm_MDS: #COVID19 | Led by Professor Jon Deeks (@deeksj), scientists have analysed worldwide data to examine the accuracy of #antib…
RT @CochraneJapan: COVID19の抗体検査の診断精度レビューが出版されました! 感度は非常に低く診断には有用でなさそうでした。一方、症状発症後15日以上経過しての使用は既感染の検出に有用な可能性が高いです。ただ、抗体の上昇期間は不明であり、症状発症後35日を…
RT @giordanopg: Nueva revisión Cochrane que resalta lo bueno y lo incierto de las pruebas de anticuerpos: https://t.co/UgGzq1PWUe
What does "testing" mean? Pooled analysis of ~16000 tests shows timing of testing matters: Hospitalized patients within 2-5 weeks after start of symptoms had the most accurate diagnostic results for COVID antibodies. https://t.co/BTFWGvOjaj
RT @GrimshawJeremy: Excellent work by @deeksj and colleagues for @cochranecollab! Antibody tests for identification of current and past inf…
RT @cochranecollab: JUST PUBLISHED - Antibody tests for identification of current and past infection with SARS‐CoV‐2 https://t.co/QTVoiTtDM…
RT @cochranecollab: JUST PUBLISHED - Antibody tests for identification of current and past infection with SARS‐CoV‐2 https://t.co/QTVoiTtDM…
RT @cochranecollab: JUST PUBLISHED - Antibody tests for identification of current and past infection with SARS‐CoV‐2 https://t.co/QTVoiTtDM…
Nueva revisión Cochrane que resalta lo bueno y lo incierto de las pruebas de anticuerpos: https://t.co/UgGzq1PWUe
So many uncertainties about #COVID19 antibody testing remain It's available in primary care but we need clear guidance @rcgp @PHE_uk @NHSEngland who is working on guidance for this?
RT @unibirm_MDS: #COVID19 | Led by Professor Jon Deeks (@deeksj), scientists have analysed worldwide data to examine the accuracy of #antib…
#COVID19 | Led by Professor Jon Deeks (@deeksj), scientists have analysed worldwide data to examine the accuracy of #antibody tests for COVID-19. Data shows that the timing of testing is critical: https://t.co/VutDozw1Bg Read the paper at @cochranecollab:
RT @CochraneJapan: COVID19の抗体検査の診断精度レビューが出版されました! 感度は非常に低く診断には有用でなさそうでした。一方、症状発症後15日以上経過しての使用は既感染の検出に有用な可能性が高いです。ただ、抗体の上昇期間は不明であり、症状発症後35日を…
RT @CochraneJapan: COVID19の抗体検査の診断精度レビューが出版されました! 感度は非常に低く診断には有用でなさそうでした。一方、症状発症後15日以上経過しての使用は既感染の検出に有用な可能性が高いです。ただ、抗体の上昇期間は不明であり、症状発症後35日を…
RT @ijmarshall: This was no 2-year review... hugely impressive
RT @cochranecollab: JUST PUBLISHED - Antibody tests for identification of current and past infection with SARS‐CoV‐2 https://t.co/QTVoiTtDM…
RT @tlassers: Test timing best in testing times? #COVID19 antibody test accuracy assessed in new @CochraneLibrary review https://t.co/qsrJ…
RT @dccrene: Can we use antibody tests to show past infections? Timing is everything but most data from patients who were hospitalised so h…
RT @tlassers: Test timing best in testing times? #COVID19 antibody test accuracy assessed in new @CochraneLibrary review https://t.co/qsrJ…
RT @CochraneJapan: COVID19の抗体検査の診断精度レビューが出版されました! 感度は非常に低く診断には有用でなさそうでした。一方、症状発症後15日以上経過しての使用は既感染の検出に有用な可能性が高いです。ただ、抗体の上昇期間は不明であり、症状発症後35日を…
Cochrane review of 27 #COVID antibody tests finds accuracy tightly linked to test timing. IgG/IgM sensitivity 8-14 days after symptom onset = 70%, rose to 90% 15-35 days after symptom onset https://t.co/nU19ALKBY3
RT @tlassers: Test timing best in testing times? #COVID19 antibody test accuracy assessed in new @CochraneLibrary review https://t.co/qsrJ…
This was no 2-year review... hugely impressive
Excellent work by @deeksj and colleagues for @cochranecollab! Antibody tests for identification of current and past infection with SARS‐CoV‐2 - Deeks, JJ - 2020 | Cochrane Library https://t.co/xLF72OwsNL
RT @tlassers: Test timing best in testing times? #COVID19 antibody test accuracy assessed in new @CochraneLibrary review https://t.co/qsrJ…
RT @CochraneLibrary: JUST PUBLISHED - Antibody tests for identification of current and past infection with SARS‐CoV‐2 https://t.co/95qFRShB…
RT @cochranecollab: JUST PUBLISHED - Antibody tests for identification of current and past infection with SARS‐CoV‐2 https://t.co/QTVoiTtDM…
コクランから最新の抗体検査のシステマティックレビューです。 https://t.co/lBb0Vmfgyr
RT @CochraneJapan: COVID19の抗体検査の診断精度レビューが出版されました! 感度は非常に低く診断には有用でなさそうでした。一方、症状発症後15日以上経過しての使用は既感染の検出に有用な可能性が高いです。ただ、抗体の上昇期間は不明であり、症状発症後35日を…
RT @CochraneLibrary: JUST PUBLISHED - Antibody tests for identification of current and past infection with SARS‐CoV‐2 https://t.co/95qFRShB…
RT @CochraneLibrary: JUST PUBLISHED - Antibody tests for identification of current and past infection with SARS‐CoV‐2 https://t.co/95qFRShB…
Can we use antibody tests to show past infections? Timing is everything but most data from patients who were hospitalised so how useful is it for the general population?@Cochrane_IDG @deeksj @leeflang_m @annvdbruel
RT @tlassers: Test timing best in testing times? #COVID19 antibody test accuracy assessed in new @CochraneLibrary review https://t.co/qsrJ…
RT @CochraneLibrary: JUST PUBLISHED - Antibody tests for identification of current and past infection with SARS‐CoV‐2 https://t.co/95qFRShB…
RT @CochraneJapan: COVID19の抗体検査の診断精度レビューが出版されました! 感度は非常に低く診断には有用でなさそうでした。一方、症状発症後15日以上経過しての使用は既感染の検出に有用な可能性が高いです。ただ、抗体の上昇期間は不明であり、症状発症後35日を…
Great work @deeksj and colleagues!
RT @CochraneLibrary: JUST PUBLISHED - Antibody tests for identification of current and past infection with SARS‐CoV‐2 https://t.co/95qFRShB…
RT @CochraneJapan: COVID19の抗体検査の診断精度レビューが出版されました! 感度は非常に低く診断には有用でなさそうでした。一方、症状発症後15日以上経過しての使用は既感染の検出に有用な可能性が高いです。ただ、抗体の上昇期間は不明であり、症状発症後35日を…
"Antibody tests for identification of current and past infection with SARS‐CoV‐2" - https://t.co/4rRIYDA4wW - congratulations to @deeksj and brilliant team of researchers for this urgently needed systematic review!
RT @CochraneJapan: COVID19の抗体検査の診断精度レビューが出版されました! 感度は非常に低く診断には有用でなさそうでした。一方、症状発症後15日以上経過しての使用は既感染の検出に有用な可能性が高いです。ただ、抗体の上昇期間は不明であり、症状発症後35日を…
RT @rjohnsonridd: A useful study. For those of us in primary care important to note that 'Sensitivity has mainly been evaluated in hospita…
RT @CochraneJapan: COVID19の抗体検査の診断精度レビューが出版されました! 感度は非常に低く診断には有用でなさそうでした。一方、症状発症後15日以上経過しての使用は既感染の検出に有用な可能性が高いです。ただ、抗体の上昇期間は不明であり、症状発症後35日を…
RT @cochranecollab: JUST PUBLISHED - Antibody tests for identification of current and past infection with SARS‐CoV‐2 https://t.co/QTVoiTtDM…
RT @CochraneLibrary: JUST PUBLISHED - Antibody tests for identification of current and past infection with SARS‐CoV‐2 https://t.co/95qFRShB…